While testing the effects of the compounds on GBM cells U87-MG found that compound 19 (MV1035) [208] (Fig. 8) expressed inhibitory activity, further investigation found that compound 19 exerted antitumor effects by inhibiting m6A demethylase ALKBH5 activity. This evidence concerns the gene ALKBH5 and glioblastoma.